Lista de obras -

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

artículo científico publicado en 2018

Alcohol and Steatosis: The Japanese Paradox

scientific article published on 19 May 2016

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2016

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

artículo científico publicado en 2013

Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.

artículo científico publicado en 2014

Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

artículo científico publicado en 2008

Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

artículo científico publicado en 2015

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

artículo científico publicado en 2015

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

artículo científico publicado en 2016

Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 1 de abril de 2011

Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis

artículo científico publicado en 2012

Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.

artículo científico publicado en 2011

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

artículo científico publicado en 2013

Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases

artículo científico publicado en 2007

Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

artículo científico publicado en 2011

Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities

article

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.

artículo científico

Nonalcoholic Fatty Liver Disease in HIV-Infected Persons: Epidemiology and the Role of Nucleoside Reverse Transcriptase Inhibitors

article

Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree?

artículo científico publicado en 2011

Nonalcoholic fatty liver disease and aging: epidemiology to management.

artículo científico publicado en 2014

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

artículo científico

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

artículo científico publicado en 2015

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

artículo científico publicado en 2014

Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.

artículo científico publicado en 2011

Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings

artículo científico publicado en 2014

Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.

artículo científico publicado en 2013

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

artículo científico publicado en 2015

Semi-quantitative Ultrasonographic Evaluation of NAFLD

scientific article published on 17 April 2020

Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma.

artículo científico publicado en 2015

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

artículo científico publicado en 2016

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

artículo científico publicado en 2016

The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology

artículo científico publicado en 2008

Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk? ⬇️

artículo científico publicado el 16 de agosto de 2011

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight

artículo científico publicado en 2016

Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.

artículo científico publicado en 2012

Lista de obras de

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Alcohol and Steatosis: The Japanese Paradox

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.

Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease ⬇️

Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis

Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases

Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.

Nonalcoholic Fatty Liver Disease in HIV-Infected Persons: Epidemiology and the Role of Nucleoside Reverse Transcriptase Inhibitors

Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree?

Nonalcoholic fatty liver disease and aging: epidemiology to management.

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.

Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings

Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

Semi-quantitative Ultrasonographic Evaluation of NAFLD

Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma.

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology

Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk? ⬇️

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight

Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.